Thrombin stimulates phospholipase C and inhibits adenylate cyclase in human platelets. We have studied the effect of purified Si monomer, the ADP-ribosylating subunit of pertussis toxin, on these receptorcoupled G-protein-dependent activities. ADP-ribosylation of a 41 kDa protein is associated with a marked decrease in the ability of thrombin to inhibit cyclic AMP formation, but has little effect on phospholipase C. Therefore adenylate cyclase and phospholipase C appear to be modulated by different G-proteins.
INTRODUCTION
The incubation of human platelets with thrombin leads to activation of phospholipase C and is associated with the hydrolysis of membrane phosphoinositides and accumulation ofinositol trisphosphate and diacylglycerol (Rittenhouse-Simmons, 1979; Rittenhouse & Sasson, 1985; Tarver et al., 1987) . Thrombin is also a potent inhibitor of adenylate cyclase in platelets, attenuating the PGEl-stimulated increase in cyclic AMP (Aktories & Jakobs, 1984) . This action of thrombin is mediated by an inhibitory guanine nucleotide-binding protein, G, (Aktories & Jakobs, 1984) . Treatment of platelet membranes and permeabilized platelets with pertussis toxin, which ADP-ribosylates the z-subunit of G1, uncouples adenylate cyclase from the inhibitory effects of thrombin Grandt et al.., 1986) . Activation of phospholipase C is also considered to be mediated by a G-protein, since permeabilized platelets exposed to stable analogues of GTP exhibit formation of inositol phosphates (Lapetina, 1986 ) and diacylgycerol (Haslam & Davidson, 1984) , and thrombin-induced phospholipase C activation can be inhibited by GDP[S] . Such phospholipase C-directed Gprotein activity has been referred to as Gp (Cockcroft, 1987) . Studies with several cell systems have indicated that receptor-stimulated responses are inhibited when such cells are incubated with pertussis toxin (Nakamura & Ui, 1985; Verghese et al., 1985; Paris & Pouyssegur, 1986) , implying that G, may also be Gp. However, pertussis toxin has been shown to inhibit thrombininduced GTPase activity by only about 30 %, perhaps indicating that thrombin stimulates yet another Gprotein in human platelets that is relatively resistant to pertussis-toxin treatment (Grandt et al., 1986; Houslay et al., 1986) . We have undertaken further studies on the regulation of receptor-coupled enzyme activites by ADPribosylation-sensitive G-protein(s). We considered it important to use the purified ADP-ribosylating component (Si monomer) of pertussis toxin, rather than the holotoxin, to avoid the effects that the holotoxin's B (binding) subunit appears to exert (Banga et al., 1987; Rosoff et al., 1987) . The results show that platelet adenylate cyclase and phospholipase C are affected differentially by exposure of platelets to ADP-ribosylation and that adenylate cyclase is much more sensitive to such treatment.
EXPERIMENTAL
Pertussis toxin was purified, and the Si monomer was isolated and inactivated with NEM as presented elsewhere (Banga et al., 1987) . Human platelet-rich plasma, free of erythrocytes, was prepared freshly in the presence of aspirin (1 mM) as described by Rittenhouse (1983) . Platelets were washed and suspended (1.75 x 109/ml) in buffer, pH 7.1 . Just before incubation at 37°C, the platelets were diluted 5-fold with buffer containing 120 mM-KCl, 4 mM-MgCl2, 15 mM-Hepes, 25 mM-NaCl, 1 mM-NaH2PO4 1 mM-EGTA, 280 /SMCa2 , pH 7.1, and permeabilized with saponin Banga et al., 1987) (0.5 mM) and S1 monomer (0-40,tg/ml). NADP+ was included to minimize hydrolysis of NAD+ by platelets (Rosenthal et al., 1987) . The incubations were carried out at 37°C, and the reaction was stopped after 5-60 min by adding an equal volume of ice-cold 20 % (v/v) trichloroacetic acid. The precipitated material was washed with diethyl ether and analysed after onedimensional SDS/polyacrylamide-gel electrophoresis on 12.5 %-acrylamide gels as described by Brass et al. (1986) . The ADP-ribosylated band was detected by autoradiography and digested with 0. platelets. ADP-ribosylation in platelets incubated with increasing concentrations of '1 for 10 min at 37 'C is shown in the inset as a percentage of maximal ADPribosylation; the maximum is considered to be that attained in 60 min with 10 ,ug of Sl/ml.
scintillation spectrophotometry in 1.0 ml of water + 10 ml of Monofluor (National Diagnostics). Inactivation of Si by NEM was confirmed as previously described (Banga et al., 1987) .
[32P]NAD+ was separated after the above incubations on 0.1 mm-thick cellulose sheet impregnated with polyethyleneimine (Macherey-Nagel, Diiren, Germany), as described by Cassel & Pfeuffer (1978) , and its degradation was monitored by counting the radioactivity of the [32P]NAD' spot after autoradiography. PtdOH and cyclic AMP formation in permeabilized platelets Formation of PtdOH (a measure of phospholipase C) and cyclic AMP were measured in permeabilized platelets by conversion of [32P]ATP into respective products, rather than by mass analysis of diacylglycerol, inositol trisphosphate or cyclic AMP. This ensured that only the responses of permeabilized cells (and therefore substrates accessible to S1) were monitored. S, is known to be without an effect on intact platelets (Banga et al., 1987) .
Platelets were permeabilized, as described above, by adding saponin (15 5,g/ml) at zero time and incubating at 37°C in the presence of ATP (0.5 mM), NAD+ (0.5 mM) and S1 monomer (0-30 ,tg/ml); 9 min later, [y-32P]ATP (5 ,Ci/ml; NEN-Dupont) was added and the mixture allowed to equilibrate for 1 min. Platelets were then stimulated with a-thrombin (0.5 unit/ml; courtesy of Dr. Ken Mann, University of Vermont) and the incubation was quenched 2.5 min later with 3.75 vol. of chloroform/ methanol/HCl (20:40: 1, by vol.). The lipid phase was separated, and [32P]PtdOH was resolved and quantified after t.l.c. (Rittenhouse, 1983) . Adenylate cyclase activity was monitored by conversion of [ac-32P]ATP into cyclic [32P]AMP. Saponinpermeabilized platelets (3.5 x 108/ml) were incubated at 37°C for 9 min, under conditions described above, before addition of [ac-32P]ATP (5 ,uCi/ml; NEN-Dupont). After a further 60 s, buffer or thrombin (0.5 unit/ ml) was added, followed by PGE1 (500 nM) 15 s later. The incubation was continued for 2.5 min and quenched with ice-cold trichloroacetic acid (5 %). Cyclic [3H]AMP Differential modulation of adenylate cyclase and phospholipase C (12000 c.p.m.; NEN-Dupont) was added to monitor recoveries, and the cyclic [32P]AMP formed was separated and counted for radioactivity (Salomon et al., 1974) .
RESULTS AND DISCUSSION
Incubation of saponin-permeabilized platelets with purified Si monomer leads to the ADP-ribosylation of a 41 kDa protein (Fig. 1) (Rosenthal et al., 1987) . A 30 kDa protein is also found to be ADP-ribosylated in parallel with the 41 kDa band in the presence of Si (Fig. 1) ; however, do do not know whether it is a pertussis-toxin substrate in itself or a proteolytic product of the major 41 kDa substrate(s). Two other proteins, of approx. 39 and 40 kDa, are also labelled when permeabilized platelets are incubated with [32P]NAD+ and NADP+ in the absence of S, (Fig. 1) . Such endogenous ADP-ribosylating activity in platelets and erythrocytes has been reported previously (Rosenthal et al., 1987) . Although NADP+ efficiently inhibits the endogenous activity associated with platelet membranes, the activity in cytosol is little affected (Rosenthal et al., 1987 representative of three such experiments. ADP-ribosylation, as % of maximum, was calculated as described for Fig. 2 . under conditions that lead to ADP-ribosylation of the 41 kDa protein inhibits the ability of thrombin to suppress adenylate cyclase, thereby indicating that Gi is functionally modified by such treatment. The degree of such inhibition is related to the proportion of 41 kDa protein ADP-ribosylated (Fig. 3) and is not observed when S1 is inactivated with NEM (results not shown). However, thrombin-stimulated phospholipase C activity is not affected by Si to a similar extent to adenylate cyclase. Considerable inhibition of thrombin-associated effects on adenylate cyclase is observed before any inhibitory effects on thrombin-activated phospholipase C are expressed (Fig. 3) . In another set of experiments performed with a different batch of S1, phospholipase C activity was inhibited by only 22 % when the effects of thrombin in suppressing adenylate cyclase were completely reversed (Table 1 ). Thus our results indicate that these two activities can be modulated differentially by Sl. The inhibition of phospholipase C activity might become more pronounced if a significantly higher proportion of substrate were to be ADP-ribosylated, as has been achieved in cell-free platelet membrane systems incubated for 30 min with 50 4tsg of pertussis toxin/ml (O'Rourke et al., 1987) . However, increasing the concentration of S, beyond 30 ,ug/ml (the ADP-ribosylating equivalent of about 120,g of pertussis toxin/ml) was found to increase ADP-ribosylation of permeabilized platelet protein only marginally (Fig. 2, inset) . Also, incubation of platelets with saponin for longer than 10 min elevates basal PtdOH concentrations, diminishes the activation of phospholipase C in response to thrombin, and increases the amount of endogenous pr,otein degradation (S. E. Rittenhouse & H. S. Banga, unpublished work) . Thus an analysis of the relationship between ADP-ribosylation and inhibition of phospholipase C activation after extended incubations under our conditions does not appear to be feasible.
The differential effects of S-catalysed ADP-ribosylation on platelet adenylate cyclase and phospholipase C suggest that Gi is not a 'promiscuous' entity in the platelet, coupled to the thrombin receptor but free to interact with either adenylate cyclase or phospholipase C. Phospholipase C-directed 'Gp' may be quite similar to adenylate cyclase-regulating Gi, possibly differing only with regard to susceptibility to ADP-ribosylation [e.g., via blockage of the target cysteine residue (Magee et al., 1987) ]. That phospholipase C and adenylate cyclase are coupled to agonists by two different C-proteins in platelets seems more probable, in light of the following additional observations: (1) adrenaline, which efficiently inhibits adenylate cyclase via Gi (Katada et al., 1984) , does not activate platelet phospholipase C ; (2) the thromboxane A2 analogues U46619 [(15S)-hydroxy-11 a,9a-(epoxymethano)prosta-5, 1 3-dienoic acid] and ONO 11113 (9,11 -epithio-11,12-methanothromboxane A2) stimulate a phospholipase C activity in platelets that is dependent on G-protein function (Brass et al., 1987) , but are unable to inhibit adenylate cyclase (Brass et al., 1987 ; H. S. Banga & S. E. Rittenhouse, unpublished work) . Clearly, an important future direction for research on stimulus-response coupling in platelets is the isolation and complete characterization of 'Gp'.
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